European Hashish Week 2025 has formally begun, seeing hundreds of Europe’s hashish thought leaders, innovators and determination makers descend on Berlin’s huge Messe Berlin for the primary day of Mary Jane Berlin.
This 12 months, for the primary time, Enterprise of Hashish has partnered with Mary Jane to launch a devoted Enterprise-to-Enterprise Day, for a novel alternative to foster collaboration, drive innovation and discover the rising alternatives throughout the European hashish market.
With the German hashish market projected to succeed in €1.7 billion by 2028, in response to the lately launched Prohibition Companions German Hashish Report, the occasion will present a essential platform for worldwide hashish companies to have interaction with native stakeholders and acquire insights into the brand new regulatory framework and business alternatives rising in Germany.
We’ll be reporting all through the day to convey you a roundup of the important thing insights from the panels as they occur.
Increasing Past Borders – Methods for Worldwide Progress
How hashish firms can navigate advanced worldwide rules, particularly in Europe, and construct sustainable market entry methods.
UK Market Outlook
-
Robert Jappie (Fieldfisher) famous that UK market development has been sluggish — round 70,000–80,000 sufferers over seven years — however key boundaries at the moment are easing. He expects vital development forward.
-
UK is usually neglected in favour of Germany, however Jappie believes it’s not far behind and presents actual alternative.
-
Branding is taking part in a rising position within the UK, notably for Canadian merchandise — customers are keen to pay for trusted names.
-
Karan Wadhera (Casa Verde) remarked how few folks within the UK realise that medical hashish is already authorized. That is largely attributable to promoting restrictions, although firms are more and more discovering workarounds.
International Technique & Model Constructing
-
Jürgen Bickel (STORZ & BICKEL) mentioned his firm has shipped to over 120 nations. In his 25 years within the sector, progress has all the time been sluggish, however it constantly strikes ahead.
-
Each market is “fascinating,” with Germany, Australia, and now the UK providing sturdy alternatives.
-
As a result of strict advertising guidelines, social media and digital channels (like podcasts and Instagram) are important for constructing model id in hashish.
Clinics, Affected person Retention & M&A
-
Jappie recognized affected person acquisition as the largest alternative within the UK. The remainder of the availability chain is already crowded.
-
Clinics that concentrate on the cannabis-naive inhabitants are seeing the most effective development and are more and more engaging for funding.
-
Poor affected person retention was a serious purpose for early UK stagnation.
-
Bickel agreed that telemedicine has improved entry however not retention. He added that compliance, whereas pricey, is a essential differentiator in M&A offers.
-
New medical system rules and licensing necessities make operations extra advanced — however those that handle them nicely stand out.
Regulation & Cultural Normalisation
-
Yuval Soiref (Inexperienced Success 1.0) mentioned success typically comes all the way down to being first and being sensible — citing STORZ & BICKEL for instance.
-
Jappie warned that lack of regulatory readability invitations risk-taking. In Germany, for instance, the telemedicine growth could now be attracting stricter scrutiny from regulators.
-
Bickel burdened the necessity to normalise hashish politically — legalisation in Germany isn’t the endpoint. With out ongoing advocacy, the business might lose floor.
-
Soiref agreed: continued regulatory progress is important, each for enterprise and for affected person entry.
Blurred Traces – The place Medical and Leisure Hashish Overlap
As Europe’s hashish markets evolve, the division between medical and leisure use is changing into more and more ambiguous — creating each alternatives and challenges for regulators, medical doctors, and companies alike.
Medical vs. Leisure: A Shifting Divide
- Lisa Haag (MJ Universe GmbH) opened by noting that the problem lies in the truth that it’s the identical hashish, however utilized by very completely different folks — making it more and more tough to separate medical from leisure use in a significant method.
- Paul Furfaro (Village Farms Worldwide) shared classes from Canada, the place the hashish market flipped dramatically after legalisation: what was as soon as 85–90% medical is now overwhelmingly leisure. Regardless of this, he burdened the significance of defending entry for continual sickness sufferers, who depend on hashish as a essential a part of their care.
- Furfaro additionally emphasised that product positioning and messaging at the moment are extra vital than ever, as advertising methods typically blur the strains between therapeutic and way of life use — creating potential confusion for customers and regulators alike.
Self-Prognosis and the Position of the Physician
- Lisa Haag launched the idea of “secret people who smoke” — people who bypass the medical system solely, self-diagnosing and turning to leisure markets for what are successfully medical wants.
- Paul Furfaro warned that this pattern contributes to misinformation and potential hurt, as folks typically depend on anecdotal sources or unverified claims as a substitute {of professional} medical recommendation. With out correct medical steering, dosing, and monitoring, outcomes can range dramatically.
Cultural Gaps and Medical Dangers
- Massive Narstie (Massive Narstie Medical) supplied a candid evaluation of the UK’s medical hashish panorama, arguing {that a} lack of coaching and help for medical doctors is likely one of the greatest boundaries to entry. Many GPs, he mentioned, are hesitant to prescribe hashish as a result of they’re unfamiliar with it and fearful {of professional} penalties.
- He defined that this vacuum has allowed the leisure market to innovate quickly, with product sorts, codecs, and flavours that medical doctors not often encounter. Nonetheless, he maintained that the medical pathway stays the safer, extra sustainable possibility — even when it’s not as user-friendly.
- “Hashish is a medication of style,” he mentioned, highlighting that not like capsules, hashish requires individualised choice — one thing leisure platforms are presently higher geared up to supply.
Platforms, Danger Mitigation & Regulation
- Dr. Jur Can Ansay (Dr. Ansay LTD) spoke in regards to the German context, the place telemedicine has grow to be important to affected person entry because of the shortage of cannabis-literate physicians.
- He defined that his platform serves not simply as a prescription service but additionally as a risk-mitigation instrument, flagging points like habit threat — a function he mentioned stays uncommon within the business.
- Nonetheless, he famous that the benefit of entry has reached a brand new excessive: in some instances, sufferers can now acquire hashish “as simply as ordering a pizza,” reflecting each progress and the pressing want for tighter medical oversight.
Workshop Stage: Sizing Up the German Medical Hashish Market – A Information and Numbers Deep Dive
Pablo Zuanic, Managing Director, Zuanic and Associates, provides an in depth, data-rich evaluation of Germany’s medical hashish sector, exploring affected person entry, import volumes, pricing, and reimbursement, together with the broader market forces shaping its future.
Market Insights & Qualitative Traits
-
Zuanic emphasised that main knowledge gaps persist throughout the European hashish market, notably in monitoring imports, pharmacy-level gross sales, and product rejections.
-
The German market continues to indicate indicators of rising affected person entry, medical legitimacy, and investor potential, with hashish more and more considered as an ordinary a part of therapeutic care.
Import Volumes & Market Sizing
-
Since CanG took impact, medical hashish imports have elevated fivefold, a robust indicator of rising demand and improved entry infrastructure.
-
Roughly 60% of imports are believed to succeed in pharmacies, with the remaining 40% misplaced or rejected, although questions stay about why a lot doesn’t make it to pharmacy.
- Based mostly on obtainable knowledge, the estimated German market worth utilizing a €7/gram common is roughly €625 million. With larger volumes and pricing nearer to €10/gram, that determine might exceed €1 billion.
Affected person Penetration & Market Potential
-
Lively medical hashish customers are estimated to symbolize 0.4% of the German inhabitants, or roughly 338,000 sufferers, nonetheless far under North American benchmarks (~4%), however a robust place to begin for long-term development.
-
If Germany had been to succeed in North American ranges of penetration, the market might be price upwards of €70 billion, although Zuanic burdened that this can be a directional benchmark slightly than a strict forecast.
Money vs. Reimbursed Prescriptions
-
In H1 2024, medical hashish reimbursement — excluding Epidyolex, dronabinol, and different pharma cannabinoids — totalled €68 million, a 13% year-on-year improve.
-
Reimbursement is now estimated at €150 million yearly, suggesting that round 20% of the market is roofed by insurance coverage, up from 10% beforehand.
-
That leaves roughly 80% of the market as money pay
Product Combine & Remedy Shifts
-
Extracts now account for 30% of the reimbursed market, whereas flower nonetheless dominates, making up an estimated 94% of whole gross sales when combining each money and reimbursed segments.
-
Zuanic noticed a gradual shift towards medical-focused prescriptions, and an rising sophistication in how hashish is being built-in into therapy plans, particularly with extra advanced merchandise.
Market Dynamics & Export Affect
-
Stabilising hashish costs are partly pushed by export-oriented markets like Germany and Australia, that are serving to create international worth anchors.
-
The elevated give attention to extracts and the emergence of telemedicine platforms are reshaping how hashish is prescribed and accessed — notably in Germany.
Funding & Regulatory Outlook
-
Germany presents clear upside potential for buyers, particularly as affected person entry improves and the sector turns into extra structured.
-
The normalisation of hashish inside the healthcare system is accelerating, even when regulation nonetheless lags behind precise affected person demand.
-
Zuanic concluded that the sector is shifting from uncertainty to extend legitimacy and maturity, however success will depend on higher knowledge transparency, regulatory readability, and cross-border studying from extra established markets.
